...And because of this, it will be important that discussion of the ethics surrounding
germline gene editing do not frame
all gene editing applications in a dangerous light. This post was stimulated by the news releases over the last day or so, concerning a young leukemia patient in the UK who apparently has responded extremely well to an infusion of gene-edited, cancer-fighting T-cells.
e.g.
In a nutshell, the team involved used heterologous T-cells that went through a few steps of editing before infusion into the patient.
Note this has not been peer-reviewed yet, and it's only one patient. But hopefully it will be the first of many more similar good stories to come about gene editing.
No comments:
Post a Comment